* Immuno Oncology Congress (updated 2024-11-23) ~ youtor.org

Immuno Oncology Congress (updated 2024-11-23)

A study comparing infection rates in patients treated with BCMA versus CD19directed CARTs [upl. by Euv]

A study comparing infection rates in patients treated with BCMA versus CD19directed CARTs

Duration: 2:29
84 views | 1 month ago

ImmunoOncology Symposium Part 1 [upl. by Isaak]

ImmunoOncology Symposium Part 1

Duration: 2:16:45
3.1K views | 15 Nov 2023

Selecting and sequencing therapies for RR multiple myeloma [upl. by Story992]

Selecting and sequencing therapies for RR multiple myeloma

Duration: 1:38
39 views | 1 month ago

The emerging role of checkpoint inhibitors in liver cancer [upl. by Mogerly373]

The emerging role of checkpoint inhibitors in liver cancer

Duration: 1:19
57 views | 4 months ago

Overcoming resistance to PARP inhibition in ovarian cancer [upl. by Odnalor991]

Overcoming resistance to PARP inhibition in ovarian cancer

Duration: 1:22
575 views | 22 Dec 2022

A trial investigating IberVd in transplantineligible newly diagnosed multiple myeloma [upl. by Ahsoek354]

A trial investigating IberVd in transplantineligible newly diagnosed multiple myeloma

Duration: 1:10
40 views | 1 month ago

Advances in Hodgkin lymphoma treatment moving away from ABVD and BEACOPP [upl. by Okwu]

Advances in Hodgkin lymphoma treatment moving away from ABVD and BEACOPP

Duration: 1:47
40 views | 1 month ago

Intracranial CD1cCD141 myeloid dendritic cells with ipilimumab amp nivolumab in highgrade glioma [upl. by Jeffry]

Intracranial CD1cCD141 myeloid dendritic cells with ipilimumab amp nivolumab in highgrade glioma

Duration: 2:48
93 views | 2 months ago

Enhancing antitumor immunity through gut microbiota modulation [upl. by Torie]

Enhancing antitumor immunity through gut microbiota modulation

Duration: 0:52
16 views | 1 month ago

Factors to consider when selecting patients with multiple myeloma for treatment with bispecifics [upl. by Annoval]

Factors to consider when selecting patients with multiple myeloma for treatment with bispecifics

Duration: 0:42
31 views | 1 month ago

Preventing and managing infections in patients with lymphoma treated with immunosuppressive therapy [upl. by Aldis]

Preventing and managing infections in patients with lymphoma treated with immunosuppressive therapy

Duration: 1:18
48 views | 1 month ago

Identifying highrisk DLBCL and optimizing treatment for these patients [upl. by Nohtahoj]

Identifying highrisk DLBCL and optimizing treatment for these patients

Duration: 1:05
87 views | 2 months ago

Sequencing immunotherapies in multiple myeloma [upl. by Merp768]

Sequencing immunotherapies in multiple myeloma

Duration: 1:57
64 views | 5 months ago

Cardiac biomarkers for immune checkpoint inhibitorrelated myocarditis in cancer patients [upl. by Ayiak]

Cardiac biomarkers for immune checkpoint inhibitorrelated myocarditis in cancer patients

Duration: 2:15
133 views | 6 months ago

Managing patients with multiple myeloma who have failed CART therapy [upl. by Fiora]

Managing patients with multiple myeloma who have failed CART therapy

Duration: 1:12
141 views | 2 months ago

Novel treatment options for TKIresistant gastrointestinal stromal tumors [upl. by Aznarepse148]

Novel treatment options for TKIresistant gastrointestinal stromal tumors

Duration: 1:16
26 views | 1 month ago

Overcoming ontarget offtumor toxicity in AML current challenges and potential solutions [upl. by Idur]

Overcoming ontarget offtumor toxicity in AML current challenges and potential solutions

Duration: 1:45
88 views | 2 months ago

Safety and efficacy of inotuzumab ozogamicin conditioning for alloSCT in lymphoid malignancies [upl. by Anerres]

Safety and efficacy of inotuzumab ozogamicin conditioning for alloSCT in lymphoid malignancies

Duration: 2:45
63 views | 1 month ago

Being more selective when choosing myeloma candidates for CART therapy due to capacity issues [upl. by Yemiaj]

Being more selective when choosing myeloma candidates for CART therapy due to capacity issues

Duration: 1:27
1 views | 2 months ago

The future of antibodydrug conjugates in endometrial cancer [upl. by Leonore]

The future of antibodydrug conjugates in endometrial cancer

Duration: 1:43
58 views | 1 month ago

The need for novel agents to treat patients with MCL who have relapsed after targeted therapy [upl. by Aluk773]

The need for novel agents to treat patients with MCL who have relapsed after targeted therapy

Duration: 2:22
166 views | 1 month ago

5year followup of EV and pembrolizumab for lamUC in the EV103 trial [upl. by Nnylsia]

5year followup of EV and pembrolizumab for lamUC in the EV103 trial

Duration: 1:30
53 views | 1 month ago

Minimizing immunotherapyinduced toxicity in patients with GI tumors [upl. by Dermot703]

Minimizing immunotherapyinduced toxicity in patients with GI tumors

Duration: 0:38
107 views | 3 months ago

Enhancing treatment outcomes in RCC and NSCLC with Akkermansia supplements [upl. by Sirref]

Enhancing treatment outcomes in RCC and NSCLC with Akkermansia supplements

Duration: 0:59
21 views | 1 month ago

POCHI pembrolizumab CAPOX and bevacizumab in pMMRMSS CRC at ESMO 2024 [upl. by Ettedo]

POCHI pembrolizumab CAPOX and bevacizumab in pMMRMSS CRC at ESMO 2024

Duration: 0:56
19 views | 1 month ago

Looking forward to EHA 2024 key clinical trials to look out for in the myeloma space [upl. by Sorazal]

Looking forward to EHA 2024 key clinical trials to look out for in the myeloma space

Duration: 1:15
299 views | 6 months ago

ESMO ImmunoOncology Congress 2023 Access to all the latest updates in immunooncology [upl. by Kinimod593]

ESMO ImmunoOncology Congress 2023 Access to all the latest updates in immunooncology

Duration: 1:37
555 views | 25 Jul 2023

AHEADMERIT firstline pembrolizumab and BNT113 in advanced HPV16 HNSCC [upl. by Annadiana]

AHEADMERIT firstline pembrolizumab and BNT113 in advanced HPV16 HNSCC

Duration: 3:48
37 views | 1 month ago

ESMO ImmunoOncology Congress 2023 Michele Maio amp Aurélien Marabelle on why you should register [upl. by Eupheemia370]

ESMO ImmunoOncology Congress 2023 Michele Maio amp Aurélien Marabelle on why you should register

Duration: 1:14
281 views | 11 Sep 2023

POLAR pembrolizumab and olaparib in HRDpositive pancreatic cancer [upl. by Kennard]

POLAR pembrolizumab and olaparib in HRDpositive pancreatic cancer

Duration: 2:26
66 views | 3 weeks ago

Our site allows you to download your favorite videos in MP3 (audio) or MP4 (video) format in the most efficient way. You can find your favorite videos using "search" to download them.

New on site

Content Report
youtor.org / Youtor Videos converter © 2024